INsIde thIs Issue - FDAnews...De. 5 2013 CliNiCal Trial maGNifier WeeKly page 3 iDeNTifier1 SpoNSor...

Highlights of Changes This Week at ClinicalTrials.gov:New Sponsors: Six sponsors registered studies at ClinicalTrials.gov for the first time this week. Those sponsors are CS Diagnostics, Neo-vii Biotech, Phenex Pharmaceuticals, Sancilio, Zhejiang Beta Pharma and Zhejiang Hisun Pharmaceutical. For more details, see New Spon-sors on Page 2.

New Studies: One hundred and thirteen new studies were registered this week, including studies sponsored by AbbVie, Astellas, AstraZen-eca, Bausch & Lomb, Coloplast, Eli Lilly, Genentech, GlaxoSmithKline, Hoffmann-La Roche, Janssen, Medtronic, Novartis, Pfizer, St. Jude and United Pharmaceuticals. For more details, see New Studies on Page 2.

New Results: Forty-one industry-sponsored studies posted results this week, including studies by Amgen, Bayer, Boehringer Ingel-heim, Bristol-Myers Squibb, Eli Lilly, EMD Serono, Genentech, GlaxoSmithKline, H. Lundbeck, Merck, Pfizer, Sanofi, Takeda and Teva. For more details, see New Results on Page 7.

New Study Status: One hundred and eighty-three studies are reporting changes in their status as planning, recruiting, ongoing or completed this week. Among the sponsors are Abbott, Astellas, AstraZeneca, Bausch & Lomb, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, Genentech, Gilead, GlaxoSmithKline, H. Lundbeck, Hoffmann-La Roche, Janssen, Merck, Novo Nordisk, Pfizer, Sanofi and UCB. For more details, see New Study Status on Page 9.

Vol. 2, No. 49Dec. 5, 2013

New Sponsors ..........Page 2

New Studies .............Page 2

New Results .............Page 7

New Study Status .....Page 9

Studies Opening a First Site in a New Country ...Page 15

Studies Opening Additional Sites in a Country ..Page 25

Study Sites by Country ..................Page 44

Studies Under Planning .................Page 45

Studies Ended or Halted .....................Page 55

INsIde thIs Issue

Summary of laTeST Trial upDaTeS

Week ending Dec. 5 Nov. 28 Nov. 21 Nov. 14 Total

New Sponsors 6 15 21 13 55New Studies 113 280 144 135 672New Results 41 84 45 28 198New Study Status 183 156 211 231 781Studies Opening a First Site in a New Country 238 269 304 379 1,190Studies Opening Additional Sites in a Country 452 495 558 834 2,339Studies Under Planning 287 288 279 267 1,121Studies Ended or Halted 9 19 25 13 66

(See Highlights, Page 2)

CliniCal Trial Magnifier Weekly Dec. 5, 2013page 2

Studies Opening a First Site in a New Country: Two hundred and thirty-eight new study sites launched this week in countries where the sponsors did not have study sites. For more details, see Studies Opening a First Site in a New Country on Page 15.

Studies Opening Additional Sites in a Country: Four hundred and fifty-two new study sites launched this week in countries where the sponsors already had study sites. For more details, see Studies Opening Addi-tional Sites in a Country on Page 25.

Study Sites by Country: A handy table that lists all countries with first-time and additional study sites that launched this week can be found at Study Sites by Country on Page 44.

Studies Under Planning: About 10% of the studies listed as in the planning stage are replaced each week. This week’s 287 listings include planned studies at Abbott, AstraZeneca, Bayer, Biogen Idec, Celgene, Daiichi Sankyo, Eisai, Gilead, Hoffmann-La Roche, Janssen, Medtronic, Novartis, Otsuka, Perle, Pfizer, Sanofi, St. Jude, Takeda, Teva and UCB. For more details, see Studies Under Planning on Page 45.

Studies Ended or Halted: Nine studies were terminated, suspended or withdrawn this week, includ-ing studies sponsored by Amgen, Bristol-Myers Squibb, Cubist and Merck. For more details, see Studies Ended or Halted on Page 55.

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGeDiSeaSe/

CoNDiTioN

NCT01997268 SANCILIO DRUG 1. PLANNING 3 32018

YEARS N/A

CARDIO CHOLES-TEROL/LIPIDS

NCT01999101 PHENEX DRUG 2. RECRUITING 2 1218

YEARS 70

YEARS GI LIVER FATTY

NCT01998620 ZHEJIANG HISUN

DRUG 2. RECRUITING 4 24018

YEARS 65

YEARS INFECT HEPATITIS B

NCT01999660 CS DIAGNOSTICS

DEVICE 2. RECRUITING NA 25018

YEARS N/A

ONC UROLOGY: PROSTATE

NCT01929200 ZHEJIANG BETA DRUG 3. ONGOING 2 12018

YEARS 75

YEARS ONC RESP: LUNG

NCT01324934 NEOVII DRUG 7. TERMINATED 3 4018

YEARS 75

YEARS UROLOGY KIDNEY TRANSPLANT

Highlights, from Page 1

NeW SpoNSorS

This table lists new sponsors that have never previously registered studies at ClinicalTrials.gov.

NeW STuDieS

This table lists every new study registered in the past week.


CoNDiTioN

NCT01994668 PFIZER DRUG 1. PLANNING 1 820

YEARS 55

YEARS HEALTHY/PHARM

NCT01995227 IMMUNOVATIVE BIOLOGICAL 1. PLANNING 1 200 18 YEARS N/A ONC GI: LIVER

NCT01995526 ELI LILLY DRUG 1. PLANNING 1 1020

YEARS 45

YEARS HEALTHY/PHARM

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(See New Studies, Page 3)(Return to Page 1)

http://www.clinicaltrials.gov/ct2/show/NCT01997268http://www.clinicaltrials.gov/ct2/show/NCT01999101http://www.clinicaltrials.gov/ct2/show/NCT01998620http://www.clinicaltrials.gov/ct2/show/NCT01999660http://www.clinicaltrials.gov/ct2/show/NCT01929200http://www.clinicaltrials.gov/ct2/show/NCT01324934http://www.clinicaltrials.gov/ct2/show/NCT01994668http://www.clinicaltrials.gov/ct2/show/NCT01995227http://www.clinicaltrials.gov/ct2/show/NCT01995526

CliniCal Trial Magnifier WeeklyDec. 5, 2013 page 3


CoNDiTioN

NCT01995656 ELI LILLY DRUG 1. PLANNING 1 4421

YEARS 65

YEARS ENDO DIABETES

NCT01997164 REGENERON DRUG 1. PLANNING 1 6018

YEARS N/A

OPHTHAL DIABETIC

NCT01997840 ACETYLON DRUG 1. PLANNING 1 10018

YEARS N/A

ONC HEM: MYELOMA

NCT01997905 ATRICURE DEVICE 1. PLANNING 1 3018

YEARS 80

YEARS CARDIO ARRHYT/FIBRILL

NCT01998542 IMMUNOVATIVE BIOLOGICAL 1. PLANNING 1 5218

YEARS 70

YEARS ONC ENT: NPC

NCT01998971 JANSSEN DRUG 1. PLANNING 1 4018

YEARS N/A

ONC HEM: MYELOMA

NCT01999725 ENANTA DRUG 1. PLANNING 1 6418

YEARS 45

YEARS HEALTHY/PHARM

NCT01999803 NEURONOVA DRUG 1. PLANNING 1 1818

YEARS 75

YEARS NEUR ALS

NCT01999842 GSK BIOLOGICAL 1. PLANNING 1 42018

YEARS 64

YEARS INFECT INFLUENZA/FLU


YEARS N/A

ONC SOLID TUMOR/CANCER

NCT01995058 EXELIXIS DRUG 1. PLANNING 2 28018

YEARS N/A


NCT01995071 ABBVIE DRUG 1. PLANNING 2 8018

YEARS 70

YEARS INFECT HEPATITIS C

NCT01995487 MEDINOL DEVICE 1. PLANNING 2 1,90618

YEARS N/A

CARDIO CORO-NARY/ISCHEMIC

NCT01995500 MEDINOL DEVICE 1. PLANNING 2 30018

YEARS N/A

CARDIO CORO-NARY/ISCHEMIC

NCT01995838 EISAI DRUG 1. PLANNING 2 30018

YEARS 80

YEARS PSYCH INSOMNIA/SLEEP

NCT01998828 GILEAD DRUG 1. PLANNING 2 8018

YEARS N/A

HEM POLYCYTHE-MIA VERA

NCT01998958 JANSSEN DRUG 1. PLANNING 2 10018

YEARS 64

YEARS PSYCH DEPRESSION

NCT01998984 LEO DRUG 1. PLANNING 2 240 18 YEARS N/A DERM KERATOSIS

NCT01999582 CELGENE BIOLOGICAL 1. PLANNING 2 6018

YEARS N/A HEM ANEMIA

NCT01994720 ASTRAZENECA DRUG 1. PLANNING 3 9,60040

YEARS N/A CARDIO STROKE


YEARS 90

YEARS NEUR AMYLOIDOSIS

NCT01994967 CRISTALIA DRUG 1. PLANNING 3 12018

YEARS 80

YEARS ORTH SPINAL DISEASE

NCT01995266 BMS DRUG 1. PLANNING 3 15018

YEARS N/A

INFECT HEPATITIS C

NCT01996319 NOVARTIS DRUG 1. PLANNING 3 15040

YEARS N/A RESP COPD

New Studies, from Page 2



http://www.clinicaltrials.gov/ct2/show/NCT01995656http://www.clinicaltrials.gov/ct2/show/NCT01997164http://www.clinicaltrials.gov/ct2/show/NCT01997840http://www.clinicaltrials.gov/ct2/show/NCT01997905http://www.clinicaltrials.gov/ct2/show/NCT01998542http://www.clinicaltrials.gov/ct2/show/NCT01998971http://www.clinicaltrials.gov/ct2/show/NCT01999725http://www.clinicaltrials.gov/ct2/show/NCT01999803http://www.clinicaltrials.gov/ct2/show/NCT01999842http://www.clinicaltrials.gov/ct2/show/NCT01999972http://www.clinicaltrials.gov/ct2/show/NCT01995058http://www.clinicaltrials.gov/ct2/show/NCT01995071http://www.clinicaltrials.gov/ct2/show/NCT01995487http://www.clinicaltrials.gov/ct2/show/NCT01995500http://www.clinicaltrials.gov/ct2/show/NCT01995838http://www.clinicaltrials.gov/ct2/show/NCT01998828http://www.clinicaltrials.gov/ct2/show/NCT01998958http://www.clinicaltrials.gov/ct2/show/NCT01998984http://www.clinicaltrials.gov/ct2/show/NCT01999582http://www.clinicaltrials.gov/ct2/show/NCT01994720http://www.clinicaltrials.gov/ct2/show/NCT01994889http://www.clinicaltrials.gov/ct2/show/NCT01994967http://www.clinicaltrials.gov/ct2/show/NCT01995266http://www.clinicaltrials.gov/ct2/show/NCT01996319



CoNDiTioN

NCT01996839 BAUSCH & LOMB

DRUG 1. PLANNING 3 48318

YEARS N/A

RHEUM INFLAMMATION

NCT01996865 CELGENE DRUG 1. PLANNING 3 50018

YEARS N/A

ONC HEM: LYMPHOMA

NCT01997229 ALEXION BIOLOGICAL 1. PLANNING 3 9218

YEARS N/A

NEUR MYASTHE-NIA GRAVIS

NCT01997268 SANCILIO DRUG 1. PLANNING 3 32018

YEARS N/A


NCT01998165 JANSSEN DRUG 1. PLANNING 3 80 1 YEAR 15

YEARS ANEST ANALGESIC

NCT01998802 ELEVEN DRUG 1. PLANNING 3 73018

YEARS N/A

OPHTHAL DRY EYE

NCT01999218 MERCK DRUG 1. PLANNING 3 1,23018

YEARS N/A ENDO DIABETES

NCT01999673 PEREGRINE BIOLOGICAL 1. PLANNING 3 58218

YEARS N/A ONC RESP: LUNG

NCT01999686 DEXA DRUG 1. PLANNING 3 18618

YEARS 40

YEARS O&G OVARY CYST

NCT01999777 UPSHER-SMITH DRUG 1. PLANNING 3 4812

YEARS 65

YEARS NEUR EPILEPSY/SEIZURE

NCT01997450 MEDIMMUNE 1. PLANNING 4 5,200 2 YEARS 17


NCT01995175 GSK PROCEDURE 1. PLANNING NA 3,000 N/A 5 DAYS INFECT RESP SYNCYTIAL

NCT01995552 MEDTRONIC DEVICE 1. PLANNING NA 30018

YEARS N/A CARDIO INFARCT

NCT01995604 MILTENYI OTHER 1. PLANNING NA 2018

YEARS N/A

DERM SCAR/INJURY

NCT01995682 NESTLE 1. PLANNING NA 25065

YEARS 90

YEARS HEALTHY/PHARM

NCT01996709 ALCON DEVICE 1. PLANNING NA 12018

YEARS N/A

OPHTHAL MYOPIA

NCT01997736 TORAY DEVICE 1. PLANNING NA 3518

YEARS N/A

CARDIO ARRHYT/FIBRILL

NCT01998412 ALIMERA 1. PLANNING NA 800 N/A N/A HEALTHY/PHARM

NCT02000115 ST JUDE DEVICE 1. PLANNING NA 1,61021

YEARS N/A CARDIO VALVE

NCT01995188 GENENTECH DRUG 2. RECRUITING 1 4218

YEARS N/A ONC O&G: OVARY

NCT01995383 HOFFMANN-LA ROCHE


YEARS 45

YEARS CARDIO PERIPH VASC

NCT01995617 GENOCEA BIOLOGICAL 2. RECRUITING 1 9018

YEARS 55

YEARS INFECT PNEUMONIA

NCT01996228 TIANHE STEM CELL

DEVICE 2. RECRUITING 1 20 6 YEARS 14

YEARS ENDO DIABETES

NCT01997190 ADVANTAGENE BIOLOGICAL 2. RECRUITING 1 1918

YEARS N/A

ONC RESP: PLEURA







CoNDiTioN

NCT01997944 BEIJING BIO-FORTUNE

BIOLOGICAL 2. RECRUITING 1 4018

YEARS 65


NCT01997983 THERACOAT DEVICE 2. RECRUITING 1 1518

YEARS 65

YEARS INFECT CYSTITIS

NCT01999335 ONYX DRUG 2. RECRUITING 1 31418

YEARS N/A

ONC HEM: MYELOMA

NCT01999738 ENDOCYTE DRUG 2. RECRUITING 1MISS-ING

18 YEARS

N/A ONC SOLID TUMOR/CANCER

NCT02000154 SYMBIO DRUG 2. RECRUITING 1 1220

YEARS N/A

ONC HEM: MY-ELODYSPLASTIC

NCT01994629 NOVARTIS BIOLOGICAL 2. RECRUITING 2 20012

MONTHS 15

MONTHS INFECT MENINGOCOCCAL

NCT01994837 ABBVIE DRUG 2. RECRUITING 2 5418

YEARS N/A

ONC HEM: LEUKEMIA

NCT01996254 NDI MEDICAL DEVICE 2. RECRUITING 2 5418

YEARS N/A

ORTH AMPUT/PROSTHESEIS

NCT01997333 CELLDEX DRUG 2. RECRUITING 2 30018

YEARS N/A ONC BREAST


YEARS 60

YEARS NEUR ALZHEIM-ER/DEMENT

NCT01999101 PHENEX DRUG 2. RECRUITING 2 1218

YEARS 70


NCT01999192 BIOTEST DRUG 2. RECRUITING 2 30418

YEARS 75

YEARS RHEUM ARTHRITIS/GOUT

NCT01999764 QLT DRUG 2. RECRUITING 2 4060

YEARS N/A

OPHTHAL EYE DISEASE

NCT01994642 PAR DRUG 2. RECRUITING 3 5006

MONTHS 12

YEARS INFECT OTITIS



YEARS N/A

RHEUM ARTHRITIS/GOUT

NCT01998477 NOVARTIS BIOLOGICAL 2. RECRUITING 3 504 3 YEARS 17


NCT01999322 NOVO NORDISK DRUG 2. RECRUITING 3 36 18 YEARS N/A ENDO DIABETES

NCT01995136 ALCON DRUG 2. RECRUITING 4 3420

YEARS N/A

OPHTHAL GLAUCOMA

NCT01995513 MEDIVATION DRUG 2. RECRUITING 4 50018

YEARS N/A


NCT01997385 FRESENIUS PROCEDURE 2. RECRUITING 4 12820

YEARS 75

YEARS UROLOGY KIDNEY FAILURE

NCT01998620 ZHEJIANG HISUN


YEARS 65


NCT01994798 TERUMO 2. RECRUITING NA 52518

YEARS N/A

CARDIO PERIPH VASC

NCT01994902 COLOPLAST DEVICE 2. RECRUITING NA 223 18 YEARS N/A GI STOMY

NCT01995357 COLOPLAST DEVICE 2. RECRUITING NA 26 18 YEARS N/A GI STOMY

NCT01996033 ST JUDE 2. RECRUITING NA 50018

YEARS N/A

CARDIO HYPERTENSION


(See New Studies, Page 6)


(Return to Page 1)

http://www.clinicaltrials.gov/ct2/show/NCT01997944http://www.clinicaltrials.gov/ct2/show/NCT01997983http://www.clinicaltrials.gov/ct2/show/NCT01999335http://www.clinicaltrials.gov/ct2/show/NCT01999738http://www.clinicaltrials.gov/ct2/show/NCT02000154http://www.clinicaltrials.gov/ct2/show/NCT01994629http://www.clinicaltrials.gov/ct2/show/NCT01994837http://www.clinicaltrials.gov/ct2/show/NCT01996254http://www.clinicaltrials.gov/ct2/show/NCT01997333http://www.clinicaltrials.gov/ct2/show/NCT01998841http://www.clinicaltrials.gov/ct2/show/NCT01999101http://www.clinicaltrials.gov/ct2/show/NCT01999192http://www.clinicaltrials.gov/ct2/show/NCT01999764http://www.clinicaltrials.gov/ct2/show/NCT01994642http://www.clinicaltrials.gov/ct2/show/NCT01995201http://www.clinicaltrials.gov/ct2/show/NCT01998477http://www.clinicaltrials.gov/ct2/show/NCT01999322http://www.clinicaltrials.gov/ct2/show/NCT01995136http://www.clinicaltrials.gov/ct2/show/NCT01995513http://www.clinicaltrials.gov/ct2/show/NCT01997385http://www.clinicaltrials.gov/ct2/show/NCT01998620http://www.clinicaltrials.gov/ct2/show/NCT01994798http://www.clinicaltrials.gov/ct2/show/NCT01994902http://www.clinicaltrials.gov/ct2/show/NCT01995357http://www.clinicaltrials.gov/ct2/show/NCT01996033



CoNDiTioN

NCT01997099 SMITHS MEDICAL


YEARS N/A

OTHER HEALTH CARE

NCT01998607 AMGEN OTHER 2. RECRUITING NA 420 N/A N/A ONC SOLID TUMOR/CANCER

NCT01998737 BONE INDEX 2. RECRUITING NA 1,10050

YEARS 79

YEARS ENDO OSTEOPOROSIS

NCT01998867 HEALTH DIAGNOSTIC

2. RECRUITING NA 1,00018


NCT01999348 ALLERGAN DRUG 2. RECRUITING NA 2,000 N/A N/A OPHTHAL GLAUCOMA

NCT01999543 UNILEVER DIETARY SUP.

2. RECRUITING NA 12020

YEARS 50

YEARS HEALTHY/PHARM

NCT01999660 CS DIAGNOSTICS


YEARS N/A


NCT01999699 DYNAVAX BIOLOGICAL 3. ONGOING 1 3050

YEARS 70



DRUG 3. ONGOING 3 78718

YEARS N/A

ONC HEM: LEUKEMIA

NCT01995539 MEDTRONIC DEVICE 3. ONGOING NA 180 18 YEARS 70 YEARS ENDO DIABETES

NCT01996111 MILTENYI PROCEDURE 3. ONGOING NA 12018

YEARS N/A

ORTH TENDO DISEASE

NCT01998854 GYNESONICS DEVICE 3. ONGOING NA 5028

YEARS N/A

O&G MENSTRUAL MENORRHAGIA

NCT01999504 UNILEVER OTHER 3. ONGOING NA 2418

YEARS 60

YEARS ENDO DIABETES

NCT01996462 TORRENT DRUG 4. COMPLETED 1MISS-ING

18 YEARS

45 YEARS

HEALTHY/PHARM


18 YEARS

45 YEARS

HEALTHY/PHARM


18 YEARS

45 YEARS

HEALTHY/PHARM


18 YEARS

45 YEARS

HEALTHY/PHARM

NCT01997879 AERIE DRUG 4. COMPLETED 1 18 18 YEARS N/A HEALTHY/PHARM

NCT01998646 ASTELLAS DRUG 4. COMPLETED 1 130 18 YEARS 55 YEARS HEALTHY/PHARM

NCT01998659 PHENEX DRUG 4. COMPLETED 1 54 18 YEARS 45 YEARS HEALTHY/PHARM

NCT01998672 PHENEX DRUG 4. COMPLETED 1 42 18 YEARS 45 YEARS HEALTHY/PHARM

NCT01999114 PURDUE DRUG 4. COMPLETED 1 32818

YEARS 55

YEARS CARDIO FUNCTION/INVEST

NCT01999231 ANHUI ZHIFEI DRUG 4. COMPLETED 1 24 18 YEARS 40 YEARS HEALTHY/PHARM


DRUG 4. COMPLETED 2 1,79318



DRUG 4. COMPLETED 2 7818

YEARS N/A

ONC HEM: LYMPHOMA





(See New Studies, Page 7)


(Return to Page 1)

http://www.clinicaltrials.gov/ct2/show/NCT01997099http://www.clinicaltrials.gov/ct2/show/NCT01998607http://www.clinicaltrials.gov/ct2/show/NCT01998737http://www.clinicaltrials.gov/ct2/show/NCT01998867http://www.clinicaltrials.gov/ct2/show/NCT01999348http://www.clinicaltrials.gov/ct2/show/NCT01999543http://www.clinicaltrials.gov/ct2/show/NCT01999660http://www.clinicaltrials.gov/ct2/show/NCT01999699http://www.clinicaltrials.gov/ct2/show/NCT01998880http://www.clinicaltrials.gov/ct2/show/NCT01995539http://www.clinicaltrials.gov/ct2/show/NCT01996111http://www.clinicaltrials.gov/ct2/show/NCT01998854http://www.clinicaltrials.gov/ct2/show/NCT01999504http://www.clinicaltrials.gov/ct2/show/NCT01996462http://www.clinicaltrials.gov/ct2/show/NCT01996475http://www.clinicaltrials.gov/ct2/show/NCT01996488http://www.clinicaltrials.gov/ct2/show/NCT01996501http://www.clinicaltrials.gov/ct2/show/NCT01997879http://www.clinicaltrials.gov/ct2/show/NCT01998646http://www.clinicaltrials.gov/ct2/show/NCT01998659http://www.clinicaltrials.gov/ct2/show/NCT01998672http://www.clinicaltrials.gov/ct2/show/NCT01999114http://www.clinicaltrials.gov/ct2/show/NCT01999231http://www.clinicaltrials.gov/ct2/show/NCT01996332http://www.clinicaltrials.gov/ct2/show/NCT01998893http://www.clinicaltrials.gov/ct2/show/NCT01998919



CoNDiTioN

NCT01999894 FOREST DRUG 4. COMPLETED 2 102 6 YEARS 18 YEARS PSYCH AUTISM

NCT01996748 SALVAT DRUG 4. COMPLETED 3 13512

YEARS N/A

ALLERGY ECZE-MA/DERMATITIS




NCT01994876 COLOPLAST DEVICE 4. COMPLETED NA 18 18 YEARS N/A GI STOMY

NCT01996787 SAUFLON DEVICE 4. COMPLETED NA 3819

YEARS 56

YEARS OPHTHAL HYPEROPIA

NCT01997151 PRO-CHANGE BEHAVIORAL 4. COMPLETED NA 37418

YEARS N/A

PSYCH MENTAL DISEASE

NCT01997216 ALCON DEVICE 4. COMPLETED NA 4218

YEARS N/A

OPHTHAL MYOPIA

NCT01997892 AMGEN OTHER 4. COMPLETED NA 1,030 18 YEARS N/A HEM ANEMIA

NCT01998074 UNITED PHAR-MACEUTICALS

DIETARY SUP.

4. COMPLETED NA MISS-ING

N/A 6

MONTHS ALLERGY ASTHMA

NCT01995734 NOVARTIS DRUG 7. OTHER 4MISS-ING

18 YEARS

N/A ENDO ACROMEGALY

NCT01994863 COLOPLAST DEVICE 7. TERMINATED 2 25 18 YEARS N/A GI STOMY


NeW reSulTS

This table lists all industry-sponsored studies with results posted during the past week.

iDeNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01106391 CORDIS DEVICE 3. ONGOING 2 6018

YEARS N/A CARDIO ANEURYSM


DRUG 3. ONGOING 2 45 3 YEARS 17

YEARS ONC CNS: GLIOMA

NCT00762034 ELI LILLY DRUG 3. ONGOING 3 93918


NCT01309243 GILEAD DRUG 3. ONGOING 3 799 18 YEARS N/A INFECT HIV/AIDS

NCT01431963 GSK DRUG 3. ONGOING 3 7016

YEARS N/A

NEUR EPILEPSY/SEIZURE

NCT01272284 COLOPLAST DEVICE 3. ONGOING NA 11318

YEARS N/A

UROLOGY INCONTINENCE

NCT00439270 BMS DRUG 4. COMPLETED 1 4918

YEARS N/A


NCT00711997 BIOCANCELL BIOLOGICAL 4. COMPLETED 1 918

YEARS 79

YEARS ONC GI: PANCREAS

NCT00985959 JANSSEN DRUG 4. COMPLETED 1 101 20 YEARS N/A ONC HEM: MYELOMA

NCT01537120 MERCK DRUG 4. COMPLETED 1 2518

YEARS 79

YEARS ENDO DIABETES

NCT00617773 RECEPTA BIOLOGICAL 4. COMPLETED 2 3118

YEARS N/A

ONC O&G: FALLOPIAN TUBE

NCT00753675 ASTRAZENECA DRUG 4. COMPLETED 2 17418

YEARS N/A ONC GI: BILIARY

(See New results, Page 8)


(Return to Page 1)

http://www.clinicaltrials.gov/ct2/show/NCT01999894http://www.clinicaltrials.gov/ct2/show/NCT01996748http://www.clinicaltrials.gov/ct2/show/NCT01998906http://www.clinicaltrials.gov/ct2/show/NCT01994876http://www.clinicaltrials.gov/ct2/show/NCT01996787http://www.clinicaltrials.gov/ct2/show/NCT01997151http://www.clinicaltrials.gov/ct2/show/NCT01997216http://www.clinicaltrials.gov/ct2/show/NCT01997892http://www.clinicaltrials.gov/ct2/show/NCT01998074http://www.clinicaltrials.gov/ct2/show/NCT01995734http://www.clinicaltrials.gov/ct2/show/NCT01994863http://www.clinicaltrials.gov/ct2/show/NCT01106391http://www.clinicaltrials.gov/ct2/show/NCT01118377http://www.clinicaltrials.gov/ct2/show/NCT00762034http://www.clinicaltrials.gov/ct2/show/NCT01309243http://www.clinicaltrials.gov/ct2/show/NCT01431963http://www.clinicaltrials.gov/ct2/show/NCT01272284http://www.clinicaltrials.gov/ct2/show/NCT00439270http://www.clinicaltrials.gov/ct2/show/NCT00711997http://www.clinicaltrials.gov/ct2/show/NCT00985959http://www.clinicaltrials.gov/ct2/show/NCT01537120http://www.clinicaltrials.gov/ct2/show/NCT00617773http://www.clinicaltrials.gov/ct2/show/NCT00753675



maX aGe

DiSeaSe/ CoNDiTioN

NCT01040871 MILLENNIUM DRUG 4. COMPLETED 2 16418

YEARS N/A

ONC HEM: LYMPHOMA

NCT01339936 OPTOMETRIC DEVICE 4. COMPLETED 2 40 18 YEARS N/A OPHTHAL DRY EYE

NCT01388491 TEVA DRUG 4. COMPLETED 2 293 18 YEARS 40 YEARS SURG COMPLICATION

NCT00213135 EMD SERONO DRUG 4. COMPLETED 3 1,32618

YEARS 65

YEARS NEUR MULTIPLE SCLEROSIS

NCT00387764 GSK DRUG 4. COMPLETED 3 8018

YEARS N/A

ONC UROLOGY: KIDNEY

NCT00641537 EMD SERONO DRUG 4. COMPLETED 3 86718

YEARS 65

YEARS NEUR MULTIPLE SCLEROSIS

NCT00656136 BOEHRINGER INGELHEIM



NCT00856284 TAKEDA DRUG 4. COMPLETED 3 2,639 18 YEARS 80 YEARS ENDO DIABETES

NCT01092507 SANOFI BIOLOGICAL 4. COMPLETED 3 3009

MONTHS 18

MONTHS INFECT ENCEPHA-LITIS

NCT01189747 ALLERGAN BIOLOGICAL 4. COMPLETED 3 446 18 YEARS N/A DERM WRINKLES

NCT01189760 ALLERGAN BIOLOGICAL 4. COMPLETED 3 917 18 YEARS N/A DERM WRINKLES

NCT01264939 GENENTECH DRUG 4. COMPLETED 3 33612

YEARS 75

YEARS ALLERGY URTI-CARIA

NCT01268891 H LUNDBECK DRUG 4. COMPLETED 3 13230

YEARS N/A NEUR PARKINSON

NCT01277042 GSK BIOLOGICAL 4. COMPLETED 3 1,21226

YEARS 45

YEARS INFECT PAPILLOMA-VIRUS

NCT01491607 EMERGENT BIOSOLUTIONS

BIOLOGICAL 4. COMPLETED 3 20018

YEARS 65

YEARS INFECT ANTHRAX

NCT01642589 SANOFI BIOLOGICAL 4. COMPLETED 3 30011

YEARS 55

YEARS INFECT MENINGITIS

NCT01006603 ASTRAZENECA DRUG 4. COMPLETED 4 957 65 YEARS N/A ENDO DIABETES

NCT01124149 SHIRE DRUG 4. COMPLETED 4 72218

YEARS N/A

GI ULCERATIVE COLITIS

NCT01334866 MEDTRONIC PROCEDURE 4. COMPLETED 4 9118

YEARS 80


NCT00610155 PFIZER DRUG 4. COMPLETED NA 18 18 YEARS 75 YEARS ANEST PAIN

NCT00727571 AMGEN OTHER 4. COMPLETED NA 815 65 YEARS N/A HEM ANEMIA

NCT00731666 COLOPLAST DEVICE 4. COMPLETED NA 40 25 YEARS 75 YEARS UROLOGY ERECTILE

NCT01007656 GOLDEN BIO-TECHNOLOGY

DIETARY SUP.

4. COMPLETED NA 3120

YEARS 40

YEARS HEALTHY/PHARM

NCT01475474 RENEW MEDICAL

DEVICE 4. COMPLETED NA 9718

YEARS N/A GI INCONTINENCE

NCT01536860 MONDELAZ OTHER 4. COMPLETED NA 12 18 YEARS 55 YEARS ENDO DIABETES

NCT01634659 ALCON DEVICE 4. COMPLETED NA 330 18 YEARS N/A OPHTHAL MYOPIA

NCT01699763 BAYER DEVICE 4. COMPLETED NA 112 18 YEARS N/A ENDO DIABETES

NCT00596830 PFIZER DRUG 7. TERMINATED 3 68118

YEARS N/A


NCT01166178 NOVARTIS DRUG 7. TERMINATED 3 2918

YEARS 75



(Return to Page 1)

New results, from Page 7

http://www.clinicaltrials.gov/ct2/show/NCT01040871http://www.clinicaltrials.gov/ct2/show/NCT01339936http://www.clinicaltrials.gov/ct2/show/NCT01388491http://www.clinicaltrials.gov/ct2/show/NCT00213135http://www.clinicaltrials.gov/ct2/show/NCT00387764http://www.clinicaltrials.gov/ct2/show/NCT00641537http://www.clinicaltrials.gov/ct2/show/NCT00656136http://www.clinicaltrials.gov/ct2/show/NCT00856284http://www.clinicaltrials.gov/ct2/show/NCT01092507http://www.clinicaltrials.gov/ct2/show/NCT01189747http://www.clinicaltrials.gov/ct2/show/NCT01189760http://www.clinicaltrials.gov/ct2/show/NCT01264939http://www.clinicaltrials.gov/ct2/show/NCT01268891http://www.clinicaltrials.gov/ct2/show/NCT01277042http://www.clinicaltrials.gov/ct2/show/NCT01491607http://www.clinicaltrials.gov/ct2/show/NCT01642589http://www.clinicaltrials.gov/ct2/show/NCT01006603http://www.clinicaltrials.gov/ct2/show/NCT01124149http://www.clinicaltrials.gov/ct2/show/NCT01334866http://www.clinicaltrials.gov/ct2/show/NCT00610155http://www.clinicaltrials.gov/ct2/show/NCT00727571http://www.clinicaltrials.gov/ct2/show/NCT00731666http://www.clinicaltrials.gov/ct2/show/NCT01007656http://www.clinicaltrials.gov/ct2/show/NCT01475474http://www.clinicaltrials.gov/ct2/show/NCT01536860http://www.clinicaltrials.gov/ct2/show/NCT01634659http://www.clinicaltrials.gov/ct2/show/NCT01699763http://www.clinicaltrials.gov/ct2/show/NCT00596830http://www.clinicaltrials.gov/ct2/show/NCT01166178



maX aGe

DiSeaSe/ CoNDiTioN

NCT01370759 GIVEN IMAGING OTHER 2. RECRUITING 1 150 23 YEARS 75 YEARS HEALTHY/PHARM

NCT01837095 POLYPHOR DRUG 2. RECRUITING 1 24 18 YEARS 55 YEARS ONC BREAST



YEARS 65

YEARS HEALTHY/PHARM

NCT01933672 PFIZER DRUG 2. RECRUITING 1 30 18 YEARS 70 YEARS ENDO DIABETES

NCT01949870 ASTRAZENECA DRUG 2. RECRUITING 1 12 20 YEARS N/A ONC GI: BILIARY

NCT01953692 MERCK BIOLOGICAL 2. RECRUITING 1 100 18 YEARS N/A ONC HEM: MYELOMA

NCT01962935 ASTRAZENECA DRUG 2. RECRUITING 1 57 18 YEARS 50 YEARS RESP COPD

NCT01964872 JANSSEN DRUG 2. RECRUITING 1 78 18 YEARS 65 YEARS HEALTHY/PHARM

NCT01969617 H LUNDBECK DRUG 2. RECRUITING 1 2220

YEARS 65

YEARS PSYCH ABUSE ALCOHOL

NCT01973868 BAYER DRUG 2. RECRUITING 1 5418

YEARS N/A




YEARS N/A


NCT01976520 XEME BIOLOGICAL 2. RECRUITING 1 30 18 YEARS N/A ONC HEM: LEUKEMIA

NCT01978327 GSK DRUG 2. RECRUITING 1 4818

YEARS N/A

NEUR ALZHEIMER/DEMENT

NCT01980615 PEARL DRUG 2. RECRUITING 1 84 18 YEARS 45 YEARS HEALTHY/PHARM



YEARS 45

YEARS HEALTHY/PHARM



YEARS 55

YEARS HEALTHY/PHARM

NCT01989169 SHIRE DRUG 2. RECRUITING 1 30 18 YEARS 65 YEARS HEALTHY/PHARM


YEARS 80

YEARS ONC HEM: LYMPHOMA

NCT01203930 GILEAD DRUG 2. RECRUITING 2 104 65 YEARS N/A ONC HEM: LEUKEMIA



YEARS 65


NCT01896583 SELDAR DRUG 2. RECRUITING 2 75 18 YEARS 75 YEARS INFECT ENTERITIS

NCT01899768 GSK DRUG 2. RECRUITING 2 3018

YEARS N/A

INFECT INFLUENZA/FLU

NCT01923181 NOVO NORDISK DRUG 2. RECRUITING 2 603 18 YEARS N/A ENDO DIABETES

NCT01941043 CERECOR DRUG 2. RECRUITING 2 135 18 YEARS 70 YEARS PSYCH DEPRESSION

NCT01949441 CIRCASSIA BIOLOGICAL 2. RECRUITING 2 4018

YEARS 65

YEARS ALLERGY CONJUNCTIVITIS

NCT01955694 BAYER DRUG 2. RECRUITING 2 6618

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01959282 JANSSEN DRUG 2. RECRUITING 2 22018

YEARS N/A

GI ULCERATIVE COLITIS

NCT01966276 K-PAX DRUG 2. RECRUITING 2 12018

YEARS 59

YEARS PSYCH FATIGUE

NeW STuDy STaTuS

This table lists studies that reported updates in their status in the past week such as recruiting, ongoing or completed.


(See New Study Status, Page 10)(Return to Page 1)

http://www.clinicaltrials.gov/ct2/show/NCT01370759http://www.clinicaltrials.gov/ct2/show/NCT01837095http://www.clinicaltrials.gov/ct2/show/NCT01911611http://www.clinicaltrials.gov/ct2/show/NCT01933672http://www.clinicaltrials.gov/ct2/show/NCT01949870http://www.clinicaltrials.gov/ct2/show/NCT01953692http://www.clinicaltrials.gov/ct2/show/NCT01962935http://www.clinicaltrials.gov/ct2/show/NCT01964872http://www.clinicaltrials.gov/ct2/show/NCT01969617http://www.clinicaltrials.gov/ct2/show/NCT01973868http://www.clinicaltrials.gov/ct2/show/NCT01974258http://www.clinicaltrials.gov/ct2/show/NCT01976520http://www.clinicaltrials.gov/ct2/show/NCT01978327http://www.clinicaltrials.gov/ct2/show/NCT01980615http://www.clinicaltrials.gov/ct2/show/NCT01981005http://www.clinicaltrials.gov/ct2/show/NCT01984229http://www.clinicaltrials.gov/ct2/show/NCT01989169http://www.clinicaltrials.gov/ct2/show/NCT01992653http://www.clinicaltrials.gov/ct2/show/NCT01203930http://www.clinicaltrials.gov/ct2/show/NCT01706575http://www.clinicaltrials.gov/ct2/show/NCT01896583http://www.clinicaltrials.gov/ct2/show/NCT01899768http://www.clinicaltrials.gov/ct2/show/NCT01923181http://www.clinicaltrials.gov/ct2/show/NCT01941043http://www.clinicaltrials.gov/ct2/show/NCT01949441http://www.clinicaltrials.gov/ct2/show/NCT01955694http://www.clinicaltrials.gov/ct2/show/NCT01959282http://www.clinicaltrials.gov/ct2/show/NCT01966276



maX aGe

DiSeaSe/ CoNDiTioN

NCT01975818 BAYER DRUG 2. RECRUITING 2 148 18 YEARS N/A HEM ANEMIA

NCT01977755 ZEALAND DRUG 2. RECRUITING 2 600 18 YEARS N/A CARDIO INFARCT

NCT01987947 GENENTECH DRUG 2. RECRUITING 2 30 18 YEARS 75 YEARS ALLERGY URTICARIA

NCT01836523 NOVO NORDISK DRUG 2. RECRUITING 3 1,404 18 YEARS 75 YEARS ENDO DIABETES



YEARS 80

YEARS ONC HEM: LYMPHOMA

NCT01896895 MERZ DRUG 2. RECRUITING 3 6018

YEARS 80

YEARS OPHTHAL EYELASHES/LID



YEARS N/A

ONC HEM: LEUKEMIA

NCT01919801 SHIRE DRUG 2. RECRUITING 3 11818

YEARS N/A

DERM ANGIOEDEMA



YEARS N/A


NCT01952080 NPS DRUG 2. RECRUITING 3 36 1 YEAR 17 YEARS GI SMALL BOWEL



YEARS N/A

CARDIO PERIPH VASC

NCT01968967 PFIZER DRUG 2. RECRUITING 3 1,60018

YEARS N/A


NCT01970878 PEARL DRUG 2. RECRUITING 3 850 40 YEARS 80 YEARS RESP COPD

NCT01973218 NOVARTIS BIOLOGICAL 2. RECRUITING 3 26411

YEARS 17

YEARS INFECT MENINGOCOCCAL

NCT01973569 DAIICHI SANKYO


YEARS N/A


NCT01975376 PFIZER DRUG 2. RECRUITING 3 12,000 18 YEARS N/A CARDIO DISEASE

NCT01975389 PFIZER DRUG 2. RECRUITING 3 6,300 18 YEARS N/A CARDIO DISEASE

NCT01983241 GRIFOLS BIOLOGICAL 2. RECRUITING 3 33918

YEARS 70

YEARS ENDO ALPHA 1-ANTITRYPSIN


DRUG 2. RECRUITING 4 20 2 YEARS 17


NCT01816633 CYTOMEDIX DEVICE 2. RECRUITING 4 38018

YEARS N/A

ENDO DIABETES FOOT

NCT01817543 CYTOMEDIX DEVICE 2. RECRUITING 4 38518

YEARS N/A

DERM WOUND/ULCER

NCT01897753 PFIZER DRUG 2. RECRUITING 4 300 4 YEARS N/A PED SGA

NCT01977430 PARC TAULI DRUG 2. RECRUITING 4 3618

YEARS 90


NCT01980290 JANSSEN 2. RECRUITING 4 115 18 YEARS N/A INFECT HEPATITIS



YEARS N/A

ONC GI: COLORECTAL

NCT01923792 CIRCASSIA 2. RECRUITING NA 105 18 YEARS 64 YEARS ALLERGY ASTHMA

NCT01949428 CIRCASSIA 2. RECRUITING NA 10018

YEARS 65

YEARS ALLERGY CONJUNCTIVITIS

NCT01958125 ELECTROCORE DEVICE 2. RECRUITING NA 10818

YEARS N/A

NEUR MIGRAINE/H-ACHE

New Study Status, from Page 9






maX aGe

DiSeaSe/ CoNDiTioN

NCT01958684 BAYER DRUG 2. RECRUITING NA 500 N/A N/A O&G CONTRACEPTION

NCT01975402 PREVENTICE 2. RECRUITING NA 3050

YEARS N/A

CARDIO CARDIO-MYOP/FAILURE

NCT01979887 ALLERGAN PROCEDURE 2. RECRUITING NA 7540

YEARS N/A

OPHTHAL EYELASHES/LID

NCT01992250 SANARUS 2. RECRUITING NA 99 70 YEARS N/A ONC BREAST

NCT01305863 TISSUE GENESIS

DEVICE 3. ONGOING 1 6018

YEARS N/A

CARDIO PERIPH VASC

NCT01383603 CIRCASSIA BIOLOGICAL 3. ONGOING 1 10 18 YEARS 65 YEARS ALLERGY ASTHMA

NCT01489059 BMS BIOLOGICAL 3. ONGOING 1 15018

YEARS N/A

ONC DERM: MELANOMA

NCT01592045 UNITED THERAPEUTICS

BIOLOGICAL 3. ONGOING 1 28 N/A 8 YEARS ONC CNS: NEUROBLASTOMA

NCT01661205 ATRICURE DEVICE 3. ONGOING 1 3018

YEARS N/A




YEARS N/A

ONC HEM: LEUKEMIA

NCT01689025 NOVO NORDISK DRUG 3. ONGOING 1 1018

YEARS 64

YEARS RHEUM INFLAMMATION

NCT01714960 MERZ DRUG 3. ONGOING 1 7035

YEARS 80

YEARS OPHTHAL GLAUCOMA

NCT01809353 JANSSEN DRUG 3. ONGOING 1 32 20 YEARS 55 YEARS HEALTHY/PHARM

NCT01824368 RED DE PROCEDURE 3. ONGOING 1 1018

YEARS N/A

GI LIVER TRANSPLANT

NCT01902121 MANNKIND DRUG 3. ONGOING 1 36 18 YEARS 45 YEARS HEALTHY/PHARM

NCT01068041 PHYTOHEALTH DRUG 3. ONGOING 2 10018

YEARS 70

YEARS UROLOGY KIDNEY NEPHRITIS

NCT01403636 SANOFI DRUG 3. ONGOING 2 16218

YEARS N/A

ONC HEM: LYMPHOMA


YEARS N/A

ONC HEM: LYMPHOMA

NCT01523184 SK LIFE DRUG 3. ONGOING 2 100 18 YEARS 65 YEARS GI CONSTIPATION


YEARS N/A

DERM SCLERODERMA

NCT01680588 NAVIDEA DRUG 3. ONGOING 2 7018

YEARS 85

YEARS NEUR ALZHEIMER/DEMENT

NCT01698801 CELGENE DRUG 3. ONGOING 2 2020

YEARS N/A

ONC HEM: MYELOMA



YEARS 90

YEARS OPHTHAL GLAUCOMA

NCT01756898 ASUBIO DRUG 3. ONGOING 2 36018

YEARS 65

YEARS ALLERGY ECZEMA/DERMATITIS

NCT01757613 DOLORGIET DRUG 3. ONGOING 2 150 18 YEARS N/A DERM KERATOSIS

NCT01777555 CIVITAS DRUG 3. ONGOING 2 80 30 YEARS 80 YEARS NEUR PARKINSON

NCT01782664 GSK DRUG 3. ONGOING 2 64 18 YEARS 75 YEARS DERM PSORIASIS




http://www.clinicaltrials.gov/ct2/show/NCT01958684http://www.clinicaltrials.gov/ct2/show/NCT01975402http://www.clinicaltrials.gov/ct2/show/NCT01979887http://www.clinicaltrials.gov/ct2/show/NCT01992250http://www.clinicaltrials.gov/ct2/show/NCT01305863http://www.clinicaltrials.gov/ct2/show/NCT01383603http://www.clinicaltrials.gov/ct2/show/NCT01489059http://www.clinicaltrials.gov/ct2/show/NCT01592045http://www.clinicaltrials.gov/ct2/show/NCT01661205http://www.clinicaltrials.gov/ct2/show/NCT01677780http://www.clinicaltrials.gov/ct2/show/NCT01689025http://www.clinicaltrials.gov/ct2/show/NCT01714960http://www.clinicaltrials.gov/ct2/show/NCT01809353http://www.clinicaltrials.gov/ct2/show/NCT01824368http://www.clinicaltrials.gov/ct2/show/NCT01902121http://www.clinicaltrials.gov/ct2/show/NCT01068041http://www.clinicaltrials.gov/ct2/show/NCT01403636http://www.clinicaltrials.gov/ct2/show/NCT01472887http://www.clinicaltrials.gov/ct2/show/NCT01523184http://www.clinicaltrials.gov/ct2/show/NCT01651143http://www.clinicaltrials.gov/ct2/show/NCT01680588http://www.clinicaltrials.gov/ct2/show/NCT01698801http://www.clinicaltrials.gov/ct2/show/NCT01707381http://www.clinicaltrials.gov/ct2/show/NCT01756898http://www.clinicaltrials.gov/ct2/show/NCT01757613http://www.clinicaltrials.gov/ct2/show/NCT01777555http://www.clinicaltrials.gov/ct2/show/NCT01782664



maX aGe

DiSeaSe/ CoNDiTioN


YEARS N/A

ONC DERM: MELANOMA



YEARS N/A OPHTHAL DRY EYE

NCT01831960 INTREPID DRUG 3. ONGOING 2 50 12 YEARS N/A DERM ACNE

NCT01957202 GSK DRUG 3. ONGOING 2 70 18 YEARS 65 YEARS ALLERGY RHINITIS

NCT00777920 GILEAD DRUG 3. ONGOING 3 30018

YEARS N/A

CARDIO HYPER-TENSION PULM

NCT00925002 PFIZER DRUG 3. ONGOING 3 11018

YEARS 75

YEARS NEUR AMYLOIDOSIS

NCT01115907 SORIN DEVICE 3. ONGOING 3 200 18 YEARS N/A CARDIO VALVE

NCT01223131 SANOFI DRUG 3. ONGOING 3 150 6 YEARS 17 YEARS ENDO DIABETES

NCT01259713 GILEAD DRUG 3. ONGOING 3 354 18 YEARS N/A INFECT FUNGAL




NCT01500213 TESARO DRUG 3. ONGOING 3 55518

YEARS N/A

ONC CHEMOTHER EFFECTS

NCT01500226 TESARO DRUG 3. ONGOING 3 1,36918

YEARS N/A

ONC CHEMOTHER EFFECTS

NCT01515423 JANSSEN DRUG 3. ONGOING 3 1,43318

YEARS 70

YEARS PSYCH SCHIZOPHRENIA

NCT01603459 MERZ DRUG 3. ONGOING 3 15018

YEARS 80

YEARS NEUR SPASTICITY/PALSY

NCT01632904 INCYTE DRUG 3. ONGOING 3 11018

YEARS N/A

HEM POLYCYTHE-MIA VERA

NCT01642004 BMS BIOLOGICAL 3. ONGOING 3 264 18 YEARS N/A ONC RESP: LUNG

NCT01673867 BMS BIOLOGICAL 3. ONGOING 3 574 18 YEARS N/A ONC RESP: LUNG


YEARS N/A

ONC DERM: MELANOMA

NCT01814800 ADMA BIOLOGICAL 3. ONGOING 3 60 2 YEARS 75

YEARS IMMUNE IMMUNO-DEFICIENCY

NCT01824238 MERCK DRUG 3. ONGOING 3 6418

YEARS 80

YEARS CARDIO CHOLES-TEROL/LIPIDS

NCT01848054 OREXO DRUG 3. ONGOING 3 30018

YEARS 65

YEARS PSYCH ABUSE OPIOD/HEROIN

NCT01901185 AMGEN DRUG 3. ONGOING 3 7718

YEARS N/A


NCT01290445 PFIZER DRUG 3. ONGOING 4 904,585 N/A N/A OTHER SYMPTOM UNSPECIFIC

NCT01450631 KCI DEVICE 3. ONGOING 4 92 18 YEARS N/A SURG COMPLICATION

NCT00320372 CYBERONICS 3. ONGOING NA 800 18 YEARS N/A PSYCH DEPRESSION

NCT01331954 THERACLION DEVICE 3. ONGOING NA 20 18 YEARS N/A ONC BREAST

NCT01335412 VALNEVA BIOLOGICAL 3. ONGOING NA 20,00017

YEARS N/A

INFECT ENCEPHALITIS

NCT01355380 BAYER DRUG 3. ONGOING NA 6018

YEARS N/A

CARDIO HYPER-TENSION PULM







maX aGe

DiSeaSe/ CoNDiTioN

NCT01422629 THERACLION DEVICE 3. ONGOING NA 20 18 YEARS N/A ONC BREAST

NCT01427725 ABBOTT 3. ONGOING NA 500 N/A N/A GI PANCREAS INSUFFICIENCY

NCT01698671 MAQUET DEVICE 3. ONGOING NA 50 N/A N/A CARDIO ANEURYSM

NCT01744132 WILLS EYE BEHAVIORAL 3. ONGOING NA 3,000 18 YEARS N/A OPHTHAL DIABETIC

NCT01917461 MEMED 3. ONGOING NA 1,001 1 MONTH N/A INFECT LRTI

NCT00442806 CYTORI DRUG 4. COMPLETED 1 14 20 YEARS 80 YEARS CARDIO INFARCT

NCT01124630 DAIICHI SANKYO


YEARS N/A

ONC GI: COLORECTAL

NCT01129349 ONYX DRUG 4. COMPLETED 1 4418

YEARS N/A


NCT01246466 ATRICURE DEVICE 4. COMPLETED 1 2418

YEARS N/A


NCT01293630 SANOFI DRUG 4. COMPLETED 1 1820

YEARS 75

YEARS ONC SOLID TUMOR/CANCER

NCT01464931 AMGEN DRUG 4. COMPLETED 1 3218

YEARS N/A

UROLOGY KIDNEY FAILURE

NCT01494285 M. ARKIN DRUG 4. COMPLETED 1 157 12 YEARS 40 YEARS DERM ACNE

NCT01564225 EDIMER DRUG 4. COMPLETED 1 618

YEARS 40

YEARS DERM ECTODER-MAL DYSPLASIA

NCT01652859 TAIWAN LIPOSOME


YEARS 45

YEARS HEALTHY/PHARM

NCT01697020 NOVA LABORATORIES


YEARS 50

YEARS ONC HEM: LEUKEMIA

NCT01706783 NOVO NORDISK DRUG 4. COMPLETED 1 3520

YEARS 70

YEARS ENDO GROWTH HORMONE



YEARS N/A

OPHTHAL CORNEAL DISEASE

NCT01776619 PFIZER DRUG 4. COMPLETED 1 43 21 YEARS 55 YEARS HEALTHY/PHARM

NCT01784211 ELI LILLY DRUG 4. COMPLETED 1 76 18 YEARS 65 YEARS ENDO DIABETES

NCT01790607 ONO PHARMA DRUG 4. COMPLETED 1 20 18 YEARS 65 YEARS GI LIVER FAILURE

NCT01802918 GSK DRUG 4. COMPLETED 1 17 18 YEARS 50 YEARS INFECT HIV/AIDS

NCT01836198 ELI LILLY DRUG 4. COMPLETED 1 45 18 YEARS 65 YEARS HEALTHY/PHARM

NCT01843972 BOEHRINGER INGELHEIM


YEARS 45

YEARS HEALTHY/PHARM



YEARS N/A

OPHTHAL GLAUCOMA

NCT01921647 YUHAN DRUG 4. COMPLETED 1 95 20 YEARS 55 YEARS HEALTHY/PHARM

NCT01935869 LEO DRUG 4. COMPLETED 1 224 18 YEARS 65 YEARS DERM PSORIASIS

NCT01941199 DONG-A DRUG 4. COMPLETED 1 36 20 YEARS 45 YEARS ENDO DIABETES

NCT01452451 HANMI DRUG 4. COMPLETED 2 72 18 YEARS 65 YEARS ENDO DIABETES

NCT01500200 ALKERMES DRUG 4. COMPLETED 2 142 18 YEARS 65 YEARS PSYCH DEPRESSION

NCT01684410 GRIFOLS BIOLOGICAL 4. COMPLETED 2 4118

YEARS N/A

RESP CYSTIC FIBROSIS




http://www.clinicaltrials.gov/ct2/show/NCT01422629http://www.clinicaltrials.gov/ct2/show/NCT01427725http://www.clinicaltrials.gov/ct2/show/NCT01698671http://www.clinicaltrials.gov/ct2/show/NCT01744132http://www.clinicaltrials.gov/ct2/show/NCT01917461http://www.clinicaltrials.gov/ct2/show/NCT00442806http://www.clinicaltrials.gov/ct2/show/NCT01124630http://www.clinicaltrials.gov/ct2/show/NCT01129349http://www.clinicaltrials.gov/ct2/show/NCT01246466http://www.clinicaltrials.gov/ct2/show/NCT01293630http://www.clinicaltrials.gov/ct2/show/NCT01464931http://www.clinicaltrials.gov/ct2/show/NCT01494285http://www.clinicaltrials.gov/ct2/show/NCT01564225http://www.clinicaltrials.gov/ct2/show/NCT01652859http://www.clinicaltrials.gov/ct2/show/NCT01697020http://www.clinicaltrials.gov/ct2/show/NCT01706783http://www.clinicaltrials.gov/ct2/show/NCT01736462http://www.clinicaltrials.gov/ct2/show/NCT01776619http://www.clinicaltrials.gov/ct2/show/NCT01784211http://www.clinicaltrials.gov/ct2/show/NCT01790607http://www.clinicaltrials.gov/ct2/show/NCT01802918http://www.clinicaltrials.gov/ct2/show/NCT01836198http://www.clinicaltrials.gov/ct2/show/NCT01843972http://www.clinicaltrials.gov/ct2/show/NCT01895985http://www.clinicaltrials.gov/ct2/show/NCT01921647http://www.clinicaltrials.gov/ct2/show/NCT01935869http://www.clinicaltrials.gov/ct2/show/NCT01941199http://www.clinicaltrials.gov/ct2/show/NCT01452451http://www.clinicaltrials.gov/ct2/show/NCT01500200http://www.clinicaltrials.gov/ct2/show/NCT01684410



maX aGe

DiSeaSe/ CoNDiTioN


YEARS 45


NCT01753739 BAUSCH & LOMB DRUG 4. COMPLETED 2 615 12 YEARS N/A ALLERGY RHINITIS

NCT01929863 GSK DRUG 4. COMPLETED 2 16 30 YEARS 64 YEARS ENDO DIABETES

NCT00861380 GSK BIOLOGICAL 4. COMPLETED 3 41,188 6 WEEKS 18

MONTHS INFECT STREPTOCOCCUS

NCT00975000 AMGEN DRUG 4. COMPLETED 3 11418

YEARS N/A

UROLOGY KIDNEY FAILURE

NCT01249196 SK CHEMICALS DRUG 4. COMPLETED 3 25655

YEARS 85

YEARS NEUR ALZHEIMER/DEMENT

NCT01313299 IPSEN DRUG 4. COMPLETED 3 243 18 YEARS 80 YEARS NEUR DISEASE

NCT01325571 ASTELLAS DRUG 4. COMPLETED 3 8318

YEARS 70

YEARS NEUR MYASTHENIA GRAVIS

NCT01410435 PHARMACOSMOS DRUG 4. COMPLETED 3 3918

YEARS N/A

GI COLON INFLAMMATORY

NCT01425463 UCB DRUG 4. COMPLETED 3 247 16 YEARS 75 YEARS HEM ANEMIA IRON

NCT01473602 ELI LILLY DRUG 4. COMPLETED 3 40 50 YEARS N/A ORTH FRACTURE

NCT01516424 SUMITOMO DRUG 4. COMPLETED 3 26718

YEARS 64


NCT01571453 H LUNDBECK DRUG 4. COMPLETED 3 437 18 YEARS 65 YEARS PSYCH DEPRESSION

NCT01653262 UCB DRUG 4. COMPLETED 3 2916

YEARS N/A

NEUR EPILEPSY/SEIZURE

NCT01662440 NOVARTIS BIOLOGICAL 4. COMPLETED 3 660 18 YEARS 65 YEARS INFECT RABIES

NCT01674712 ABBOTT DRUG 4. COMPLETED 3 57418

YEARS 80


NCT01715129 IPSEN DRUG 4. COMPLETED 3 12618

YEARS N/A


NCT01806623 PFIZER DRUG 4. COMPLETED 3 157 18 YEARS 80 YEARS INFECT CANDIDIA

NCT01824667 CLASADO DIETARY SUP.

4. COMPLETED 3 40018

YEARS 65

YEARS HEALTHY/PHARM

NCT01849497 AMGEN DEVICE 4. COMPLETED 3 14918

YEARS 80



MONTHS 15

YEARS INFECT SINUSIT

NCT01961947 ASTELLAS BIOLOGICAL 4. COMPLETED 3 90020

YEARS 64


NCT01961960 ASTELLAS BIOLOGICAL 4. COMPLETED 3 5561

YEARS N/A

INFECT INFLUENZA/FLU

NCT00744939 BAYER PROCEDURE 4. COMPLETED 4 78 2 YEARS N/A DERM SKIN DISEASE

NCT01334866 MEDTRONIC PROCEDURE 4. COMPLETED 4 9118

YEARS 80


NCT01465958 GRIFOLS BIOLOGICAL 4. COMPLETED 4 18 2 YEARS 16

YEARS IMMUNE IMMUNODEFICIENCY

NCT01682161 JANSSEN DRUG 4. COMPLETED 4 15420

YEARS 65


NCT01711411 FHI 360 DEVICE 4. COMPLETED 4 427 18 YEARS 49 YEARS INFECT HIV/AIDS






iDeNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)miN aGe

maX aGe

DiSeaSe/ CoNDiTioN

NCT01905943 ALBANIA HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01994720 ARGENTINA ASTRAZENECA DRUG 1. PLANNING 3 9,60040


NCT01994720 AUSTRALIA ASTRAZENECA DRUG 1. PLANNING 3 9,60040


NCT01785875 AUSTRALIA AMGEN DRUG 2. RECRUITING 3 1,12018

YEARS N/A

ENDO HYPER-PARATHYROIDISM

NCT01928771 AUSTRALIA ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,13418

YEARS 75

YEARS ALLERGY ASTHMA

NCT01428063 AUSTRIA BMS DRUG 2. RECRUITING 2 30018

YEARS N/A

INFECT HEPATITIS C

NCT01923181 AUSTRIA NOVO NORDISK DRUG 2. RECRUITING 2 60318


NCT01999101 AUSTRIA PHENEX DRUG 2. RECRUITING 2 1218

YEARS 70


NCT01999803 BELGIUM NEURONOVA DRUG 1. PLANNING 1 1818

YEARS 75

YEARS NEUR ALS

NCT01998958 BELGIUM JANSSEN DRUG 1. PLANNING 2 10018

YEARS 64

YEARS PSYCH DEPRESSION

NCT01999582 BELGIUM CELGENE BIOLOGICAL 1. PLANNING 2 60 18 YEARS N/A HEM ANEMIA

STuDieS opeNiNG a firST SiTe iN a NeW CouNTry

This table lists studies that launched a site in a country for the first time in the past week.


(See Studies opening a first Site in a New Country, Page 16)(Return to Page 1)


maX aGe

DiSeaSe/ CoNDiTioN

NCT01751113 GSK DRUG 4. COMPLETED 4 53 40 YEARS 80 YEARS RESP COPD

NCT01777620 ALLERGAN BIOLOGICAL 4. COMPLETED 4 125 18 YEARS 65 YEARS DERM WRINKLES

NCT00937430 TRIHEALTH OTHER 4. COMPLETED NA 4021

YEARS 90

YEARS GI PELVIC PROLAPSE

NCT01210690 UCB 4. COMPLETED NA 1011

MONTH 11

MONTHS NEUR EPILEPSY/SEIZURE

NCT01460992 BIOTRONIK PROCEDURE 4. COMPLETED NA 12118

YEARS N/A

CARDIO HEART DISEASE

NCT01481571 VITROLIFE DEVICE 4. COMPLETED NA 17 18 YEARS 37 YEARS O&G INFERTILITY

NCT01548105 TRIHEALTH OTHER 4. COMPLETED NA 9618

YEARS N/A

GI PELVIC PROLAPSE

NCT01629693 ALCON DEVICE 4. COMPLETED NA 398 18 YEARS N/A OPHTHAL MYOPIA

NCT01710878 MAQUET DEVICE 4. COMPLETED NA 60 18 YEARS 85 YEARS CARDIO ANEURYSM

NCT01733732 ALCON OTHER 4. COMPLETED NA 54 18 YEARS N/A OPHTHAL DRY EYE

NCT01855659 ELPEN 4. COMPLETED NA 210 50 YEARS 90 YEARS RESP DISEASE

NCT01871714 EDIMER 4. COMPLETED NA 30 4 YEARS N/A DERM SKIN DISEASE

NCT01923779 CIRCASSIA 4. COMPLETED NA 163 18 YEARS 65 YEARS ALLERGY ASTHMA

NCT01951573 ALCON DEVICE 4. COMPLETED NA 3618

YEARS N/A

OPHTHAL PRESBYOPIA





maX aGe

DiSeaSe/ CoNDiTioN

NCT01994720 BELGIUM ASTRAZENECA DRUG 1. PLANNING 3 9,60040

YEARS N/A

CARDIO STROKE

NCT01659138 BELGIUM SANOFI DRUG 2. RECRUITING 2 9318

YEARS 70

YEARS GI ULCERATIVE COLITIS

NCT01525810 BELGIUM BMS DRUG 2. RECRUITING NA 85018

YEARS N/A

INFECT HEPATITIS C

NCT01994798 BELGIUM TERUMO 2. RECRUITING NA 52518

YEARS N/A

CARDIO PERIPH VASC

NCT01905943 BOSNIA AND HERZEGOVINA

HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01994720 BRAZIL ASTRAZENECA DRUG 1. PLANNING 3 9,60040

YEARS N/A

CARDIO STROKE

NCT01994967 BRAZIL CRISTALIA DRUG 1. PLANNING 3 12018

YEARS 80

YEARS ORTH SPINAL DISEASE

NCT01928771 BRAZIL ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,13418

YEARS 75


NCT01994720 BULGARIA ASTRAZENECA DRUG 1. PLANNING 3 9,60040

YEARS N/A

CARDIO STROKE

NCT01625286 BULGARIA ASTRAZENECA DRUG 2. RECRUITING 1 140 18 YEARS N/A ONC BREAST

NCT01470599 BULGARIA PFIZER DRUG 2. RECRUITING 2 9018

YEARS 75

YEARS GI CROHN

NCT01999192 BULGARIA BIOTEST DRUG 2. RECRUITING 2 30418

YEARS 75

YEARS RHEUM ARTHRI-TIS/GOUT

NCT01626378 BULGARIA TAURX DRUG 2. RECRUITING 3 180 N/A 79


NCT01928771 BULGARIA ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,13418

YEARS 75


NCT01897532 BULGARIA BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 4 8,30018


NCT01994720 CANADA ASTRAZENECA DRUG 1. PLANNING 3 9,60040

YEARS N/A

CARDIO STROKE

NCT01999192 CANADA BIOTEST DRUG 2. RECRUITING 2 30418

YEARS 75


NCT01835431 CANADA NOVO NORDISK DRUG 2. RECRUITING 3 346 1 YEAR 17

YEARS ENDO DIABETES

NCT01895777 CANADA BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 270 N/A 17

YEARS CARDIO THROMB/COAG

NCT01968551 CANADA GILEAD DRUG 2. RECRUITING 3 17018

YEARS N/A INFECT HIV/AIDS

NCT01994720 CHILE ASTRAZENECA DRUG 1. PLANNING 3 9,60040

YEARS N/A

CARDIO STROKE

NCT01512199 CHILE DAIICHI SANKYO



NCT01782131 CHILE MERCK DRUG 2. RECRUITING 3 600 18 YEARS N/A INFECT FUNGAL

NCT01996228 CHINA TIANHE STEM CELL

DEVICE 2. RECRUITING 1 20 6 YEARS 14

YEARS ENDO DIABETES

NCT01997944 CHINA BEIJING BIO-FORTUNE

BIOLOGICAL 2. RECRUITING 1 4018

YEARS 65



(See Studies opening a first Site in a New Country, Page 17)

Studies opening a first Site in a New Country, from Page 15

(Return to Page 1)




maX aGe

DiSeaSe/ CoNDiTioN

NCT01998620 CHINA ZHEJIANG HISUN


YEARS 65


NCT01998841 COLOMBIA GENENTECH DRUG 2. RECRUITING 2 30030

YEARS 60


NCT01626378 CROATIA TAURX DRUG 2. RECRUITING 3 180 N/A 79


NCT01689233 CROATIA TAURX DRUG 2. RECRUITING 3 700 N/A 89


NCT01994720 CZECH REP ASTRAZENECA DRUG 1. PLANNING 3 9,60040

YEARS N/A

CARDIO STROKE

NCT01509495 CZECH REP MEDTRONIC DEVICE 2. RECRUITING 1 2018

YEARS N/A

CARDIO CARDIOMYOP/FAILURE

NCT01971476 CZECH REP BOEHRINGER INGELHEIM



NCT01999192 CZECH REP BIOTEST DRUG 2. RECRUITING 2 30418

YEARS 75


NCT01928771 CZECH REP ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,13418

YEARS 75


NCT01958125 DENMARK ELECTROCORE DEVICE 2. RECRUITING NA 10818

YEARS N/A

NEUR MIGRAINE/ H-ACHE

NCT01995357 DENMARK COLOPLAST DEVICE 2. RECRUITING NA 2618

YEARS N/A GI STOMY

NCT01999192 ESTONIA BIOTEST DRUG 2. RECRUITING 2 30418

YEARS 75


NCT01905943 ESTONIA HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01600963 ETHIOPIA JANSSEN DRUG 1. PLANNING 3 60018

YEARS N/A INFECT TBC

NCT01995175 FINLAND GSK PROCEDURE 1. PLANNING NA 3,000 N/A 5 DAYS INFECT RESP SYNCYTIAL

NCT01895777 FINLAND BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 270 N/A 17

YEARS CARDIO THROMB/COAG

NCT01905943 FINLAND HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01525810 FINLAND BMS DRUG 2. RECRUITING NA 85018

YEARS N/A

INFECT HEPATITIS C

NCT01998737 FINLAND BONE INDEX 2. RECRUITING NA 1,10050

YEARS 79


NCT01953692 FRANCE MERCK BIOLOGICAL 2. RECRUITING 1 10018

YEARS N/A

ONC HEM: MYELOMA

NCT01785875 FRANCE AMGEN DRUG 2. RECRUITING 3 1,12018

YEARS N/A

ENDO HYPERPARA-THYROIDISM

NCT01836523 FRANCE NOVO NORDISK DRUG 2. RECRUITING 3 1,40418

YEARS 75

YEARS ENDO DIABETES

NCT01905943 FRANCE HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA




(Return to Page 1)

http://www.clinicaltrials.gov/ct2/show/NCT01998620http://www.clinicaltrials.gov/ct2/show/NCT01998841http://www.clinicaltrials.gov/ct2/show/NCT01626378http://www.clinicaltrials.gov/ct2/show/NCT01689233http://www.clinicaltrials.gov/ct2/show/NCT01994720http://www.clinicaltrials.gov/ct2/show/NCT01509495http://www.clinicaltrials.gov/ct2/show/NCT01971476http://www.clinicaltrials.gov/ct2/show/NCT01999192http://www.clinicaltrials.gov/ct2/show/NCT01928771http://www.clinicaltrials.gov/ct2/show/NCT01958125http://www.clinicaltrials.gov/ct2/show/NCT01995357http://www.clinicaltrials.gov/ct2/show/NCT01999192http://www.clinicaltrials.gov/ct2/show/NCT01905943http://www.clinicaltrials.gov/ct2/show/NCT01600963http://www.clinicaltrials.gov/ct2/show/NCT01995175http://www.clinicaltrials.gov/ct2/show/NCT01895777http://www.clinicaltrials.gov/ct2/show/NCT01905943http://www.clinicaltrials.gov/ct2/show/NCT01525810http://www.clinicaltrials.gov/ct2/show/NCT01998737http://www.clinicaltrials.gov/ct2/show/NCT01953692http://www.clinicaltrials.gov/ct2/show/NCT01785875http://www.clinicaltrials.gov/ct2/show/NCT01836523http://www.clinicaltrials.gov/ct2/show/NCT01905943



maX aGe

DiSeaSe/ CoNDiTioN

NCT01994902 FRANCE COLOPLAST DEVICE 2. RECRUITING NA 22318

YEARS N/A GI STOMY

NCT01976741 GERMANY BAYER DRUG 1. PLANNING 1 9218

YEARS N/A


NCT01999582 GERMANY CELGENE BIOLOGICAL 1. PLANNING 2 6018


NCT01994720 GERMANY ASTRAZENECA DRUG 1. PLANNING 3 9,60040

YEARS N/A

CARDIO STROKE

NCT01659138 GERMANY SANOFI DRUG 2. RECRUITING 2 9318

YEARS 70

YEARS GI ULCERATIVE COLITIS

NCT01665391 GERMANY GENZYME DRUG 2. RECRUITING 2 8818

YEARS N/A

UROLOGY KID-NEY NEPHRITIS

NCT01999192 GERMANY BIOTEST DRUG 2. RECRUITING 2 30418

YEARS 75


NCT01905943 GERMANY HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01999322 GERMANY NOVO NORDISK DRUG 2. RECRUITING 3 3618


NCT01958125 GERMANY ELECTROCORE DEVICE 2. RECRUITING NA 10818

YEARS N/A


NCT01996033 GERMANY ST JUDE 2. RECRUITING NA 50018

YEARS N/A

CARDIO HYPERTENSION

NCT01999348 GERMANY ALLERGAN DRUG 2. RECRUITING NA 2,000 N/A N/A OPHTHAL GLAUCOMA

NCT01999660 GERMANY CS DIAGNOSTICS


YEARS N/A


NCT01428063 GREECE BMS DRUG 2. RECRUITING 2 30018

YEARS N/A

INFECT HEPATITIS C

NCT01905943 GREECE HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01631214 GUATEMALA AMGEN DRUG 2. RECRUITING 3 4,00055

YEARS 90

YEARS O&G MENO-PAUSE & POST

NCT01999192 HUNGARY BIOTEST DRUG 2. RECRUITING 2 30418

YEARS 75


NCT01345669 HUNGARY BOEHRINGER INGELHEIM


YEARS N/A ONC ENT: NPC

NCT01877915 HUNGARY JANSSEN DRUG 2. RECRUITING 3 5,00018

YEARS 95

YEARS

CARDIO CARDIOMYOP/FAILURE

NCT01897532 HUNGARY BOEHRINGER INGELHEIM



NCT01995552 INDIA MEDTRONIC DEVICE 1. PLANNING NA 300 18 YEARS N/A CARDIO INFARCT

NCT01651403 INDIA GILEAD DRUG 2. RECRUITING 3 100 2 YEARS 11


NCT01721876 INDIA BOEHRINGER INGELHEIM

DRUG 2. RECRUITING 3 660 N/A N/A ONC HEM: LEUKEMIA

NCT01959529 INDIA NOVO NORDISK DRUG 2. RECRUITING 3 7,500 50 YEARS N/A ENDO DIABETES




(Return to Page 1)




maX aGe

DiSeaSe/ CoNDiTioN

NCT01999543 INDIA UNILEVER DIETARY SUP.


YEARS 50

YEARS HEALTHY/PHARM

NCT01999686 INDONESIA DEXA DRUG 1. PLANNING 3 18618

YEARS 40

YEARS O&G OVARY CYST

NCT01600482 IRELAND VASORUM DEVICE 2. RECRUITING NA 20718

YEARS N/A

CARDIO HEART DISEASE

NCT01995227 ISRAEL IMMUNOVATIVE BIOLOGICAL 1. PLANNING 1 20018

YEARS N/A ONC GI: LIVER

NCT01997983 ISRAEL THERACOAT DEVICE 2. RECRUITING 1 15 18 YEARS 65 YEARS INFECT CYSTITIS

NCT01393626 ISRAEL PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75

YEARS GI CROHN

NCT01679990 ISRAEL PLURISTEM BIOLOGICAL 2. RECRUITING 2 15045

YEARS 80


NCT01905943 ISRAEL HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01926886 ISRAEL HOFFMANN-LA ROCHE



NCT01897532 ISRAEL BOEHRINGER INGELHEIM



NCT01934790 ITALY BAYER DRUG 1. PLANNING 1 4018

YEARS N/A


NCT01994720 ITALY ASTRAZENECA DRUG 1. PLANNING 3 9,60040

YEARS N/A

CARDIO STROKE

NCT01971476 ITALY BOEHRINGER INGELHEIM



NCT01994629 ITALY NOVARTIS BIOLOGICAL 2. RECRUITING 2 20012

MONTHS 15

MONTHS INFECT MENINGOCOCCAL

NCT01626378 ITALY TAURX DRUG 2. RECRUITING 3 180 N/A 79


NCT01905943 ITALY HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01928771 ITALY ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,13418

YEARS 75


NCT01998477 ITALY NOVARTIS BIOLOGICAL 2. RECRUITING 3 504 3 YEARS 17


NCT01720342 ITALY MEDTRONIC PROCEDURE 2. RECRUITING NA 800 18 YEARS N/A CARDIO VALVE

NCT01995526 JAPAN ELI LILLY DRUG 1. PLANNING 1 1020

YEARS 45

YEARS HEALTHY/PHARM

NCT01966471 JAPAN HOFFMANN-LA ROCHE

DRUG 1. PLANNING 3 2,50018


NCT01994720 JAPAN ASTRAZENECA DRUG 1. PLANNING 3 9,60040

YEARS N/A

CARDIO STROKE

NCT01998165 JAPAN JANSSEN DRUG 1. PLANNING 3 80 1 YEAR 15

YEARS ANEST ANALGESIC

NCT01949870 JAPAN ASTRAZENECA DRUG 2. RECRUITING 1 1220

YEARS N/A ONC GI: BILIARY

NCT02000154 JAPAN SYMBIO DRUG 2. RECRUITING 1 1220

YEARS N/A

ONC HEM: MY-ELODYSPLASTIC




(Return to Page 1)




maX aGe

DiSeaSe/ CoNDiTioN

NCT01428063 KOREA, SOUTH BMS DRUG 2. RECRUITING 2 30018

YEARS N/A

INFECT HEPATITIS C

NCT01905943 KOREA, SOUTH HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01928771 KOREA, SOUTH ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,13418

YEARS 75


NCT01973218 KOREA, SOUTH NOVARTIS BIOLOGICAL 2. RECRUITING 3 26411

YEARS 17

YEARS INFECT MENINGOCOCCAL

NCT01997385 KOREA, SOUTH FRESENIUS PROCEDURE 2. RECRUITING 4 12820

YEARS 75


NCT01905943 LATVIA HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01999192 LITHUANIA BIOTEST DRUG 2. RECRUITING 2 30418

YEARS 75


NCT01757535 LITHUANIA CELGENE DRUG 2. RECRUITING 3 46055

YEARS N/A

ONC HEM: LEUKEMIA

NCT01905943 MACEDONIA HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01896895 MALAYSIA MERZ DRUG 2. RECRUITING 3 6018

YEARS 80

YEARS OPHTHAL EYELASHES/LID

NCT01999192 MEXICO BIOTEST DRUG 2. RECRUITING 2 30418

YEARS 75


NCT01999803 NETHERLANDS NEURONOVA DRUG 1. PLANNING 1 18 18 YEARS 75 YEARS NEUR ALS

NCT01971476 NETHERLANDS BOEHRINGER INGELHEIM



NCT01995383 NETHERLANDS HOFFMANN-LA ROCHE


YEARS 45


NCT01689233 NETHERLANDS TAURX DRUG 2. RECRUITING 3 700 N/A 89


NCT01785875 NETHERLANDS AMGEN DRUG 2. RECRUITING 3 1,12018

YEARS N/A


NCT01525810 NETHERLANDS BMS DRUG 2. RECRUITING NA 85018

YEARS N/A

INFECT HEPATITIS C

NCT01958125 NETHERLANDS ELECTROCORE DEVICE 2. RECRUITING NA 10818

YEARS N/A


NCT01525810 NEW ZEALAND BMS DRUG 2. RECRUITING NA 85018

YEARS N/A

INFECT HEPATITIS C

NCT01930188 NORWAY NOVO NORDISK DRUG 1. PLANNING 3 1,20018


NCT01684878 NORWAY HOFFMANN-LA ROCHE


YEARS N/A

ONC O&G: OVARY

NCT01994720 PERU ASTRAZENECA DRUG 1. PLANNING 3 9,60040

YEARS N/A

CARDIO STROKE

NCT01625286 PERU ASTRAZENECA DRUG 2. RECRUITING 1 140 18 YEARS N/A ONC BREAST

NCT01631214 PERU AMGEN DRUG 2. RECRUITING 3 4,00055

YEARS 90

YEARS O&G MENO-PAUSE & POST




(Return to Page 1)




maX aGe

DiSeaSe/ CoNDiTioN

NCT01928771 PERU ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,13418

YEARS 75


NCT01428063 POLAND BMS DRUG 2. RECRUITING 2 30018

YEARS N/A

INFECT HEPATITIS C

NCT01999192 POLAND BIOTEST DRUG 2. RECRUITING 2 30418

YEARS 75


NCT01682083 POLAND GSK DRUG 2. RECRUITING 3 85218

YEARS N/A

ONC DERM: MELANOMA

NCT01689233 POLAND TAURX DRUG 2. RECRUITING 3 700 N/A 89


NCT01785875 POLAND AMGEN DRUG 2. RECRUITING 3 1,12018

YEARS N/A


NCT01905943 POLAND HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01999582 PORTUGAL CELGENE BIOLOGICAL 1. PLANNING 2 6018


NCT01995201 PORTUGAL HOFFMANN-LA ROCHE


YEARS N/A

RHEUM ARTHRI-TIS/GOUT

NCT01930188 ROMANIA NOVO NORDISK DRUG 1. PLANNING 3 1,20018


NCT01994720 ROMANIA ASTRAZENECA DRUG 1. PLANNING 3 9,600 40 YEARS N/A CARDIO STROKE

NCT01669174 ROMANIA NOVARTIS DRUG 2. RECRUITING 2 60 40 YEARS 80 YEARS RESP COPD

NCT01792479 RUSSIA BIND THERAPEUTICS


YEARS N/A

ONC RESP: LUNG

NCT01999192 RUSSIA BIOTEST DRUG 2. RECRUITING 2 30418

YEARS 75


NCT01722487 RUSSIA PHARMACYCLICS DRUG 2. RECRUITING 3 27265

YEARS N/A

ONC HEM: LEUKEMIA

NCT01724346 RUSSIA PHARMACYCLICS DRUG 2. RECRUITING 3 27265

YEARS N/A

ONC HEM: LEUKEMIA

NCT01785875 RUSSIA AMGEN DRUG 2. RECRUITING 3 1,12018

YEARS N/A


NCT01905943 RUSSIA HOFFMANN-LA ROCHE


YEARS N/A

ONC HEM: LEUKEMIA

NCT01910402 RUSSIA VIIV DRUG 2. RECRUITING 3 47418

YEARS N/A INFECT HIV/AIDS

NCT01928771 RUSSIA ASTRAZENECA BIOLOGICAL 2. RECRUITING 3 1,13418

YEARS 75


NCT01468701 SAUDI ARABIA

BOEHRINGER INGELHEIM

2. RECRUITING NA 28,00018

YEARS N/A

CARDIO STROKE

NCT01999192 SERBIA BIOTEST DRUG 2. RECRUITING 2 30418

YEARS 75

YEARS RHEUM ARTHRI-

Date post:	27-Jan-2021
Category:	Documents
Upload:	others
View:	0 times
Download:	0 times

INsIde thIs Issue - FDAnews...De. 5 2013 CliNiCal Trial maGNifier WeeKly page 3 iDeNTifier1 SpoNSor...

Documents